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Abstract 
 
Endocytosis is the most prevalent entry port for viruses into cells, but viruses must 
escape from the lumen of endosomes to ensure that viral genomes reach a site for 
replication and progeny formation.  Endosomal escape also helps viruses bypass 
endo-lysosomal degradation and presentation to certain toll-like intrinsic immunity 
receptors.  The mechanisms for cytosolic delivery of non-enveloped viruses or 
nucleocapsids from enveloped viruses are poorly understood, in part because no 
quantitative assays are readily available, which directly measure the penetration of 
viruses into the cytosol. Following uptake by clathrin-mediated endocytosis or 
macropinocytosis, the non-enveloped adenoviruses penetrate from endosomes to 
the cytosol, and they traffic with cellular motors on microtubules to the nucleus for 
replication.  In this study, we present a novel single cell imaging assay, which 
quantitatively measures individual cytosolic viruses and distinguishes them from 
endosomal viruses or viruses at the plasma membrane.  Using this assay, we show 
that the penetration of human adenoviruses from the species C and B occurs rapidly 
after virus uptake.  Efficient penetration does not require acidic pH in endosomes.  
This assay is versatile, and can be adapted to other adenoviruses, and members of 
other non-enveloped and enveloped virus families.    
 3 
Introduction 
 
Cell entry of viruses involves crossing of the plasma membrane, or an endosomal 
membrane following endocytic uptake.  In fact, endocytosis is the major pathway for 
virus infections (for recent reviews, see 1, 2-5).  Enveloped viruses are well known to 
fuse their lipid membrane with the plasma membrane or the endosomal membrane, 
and thereby deliver their internal core structures into the cytoplasm.  In contrast, the 
membrane penetration of non-enveloped viruses is less well understood, but equally 
important, since it gives rise to cytosolic viruses which are sensed by intrinsic and 
innate host defense systems (for reviews, see 6, 7).  Central to non-enveloped virus 
penetration is a virally encoded membrane lytic factor, which either forms a pore on 
the limiting membrane, causes disintegration, or locally modifies the host membrane 
composition (reviewed in, 8, 9).  This eventually enables the viral capsid to traverse 
the membrane barrier and access the cytosol.  In intact non-enveloped viruses the 
membrane lytic factor is internal and its exposure requires a metastable capsid 
structure that can undergo structural rearrangements in response to cellular cues.  
The precise molecular mechanisms by which these membrane lytic factors bring 
about the virus penetration, or the host components that participate in the process, 
are poorly characterized.  One issue that has hampered the progress is the lack of 
suitable assays that can quantitatively and directly measure virus penetration 
efficiency in infected cells. 
 
Human adenoviruses are non-enveloped icosahedral viruses, replicating in the cell 
nucleus with lytic release of progeny to the medium (10).  They are classified into 
seven species (HAdV-A to G, 11).  The ~90nm outer capsid shell is formed by the 
major structural protein hexon and stabilized by minor cementing proteins (12, 13).  
Proteolytic processing of the cementing proteins by a virion-associated protease 
converts the capsid into a metastable structure that is capable of undergoing a 
stepwise uncoating during entry, and successful delivery of the viral genome into the 
nucleus (14-16).  Attachment and uptake of adenoviruses into cells are mediated by 
vertex-associated fiber and penton base proteins, respectively, after a distinct series 
of motion steps on the cell surface (17).  Coxsackievirus adenovirus receptor (CAR) 
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is the primary attachment receptor for species C adenoviruses, such as HAdV-C2 
and HAdV-C5 (18, 19), whereas integrins ανβ3 and ανβ5 mediate virus uptake via 
clathrin-mediated endocytosis (20-24).  In contrast, species B viruses bind to cells via 
CD46 or desmoglein 2 (25, 26), and are internalized by macropinocytosis (27, 28).  
Following internalization, HAdV-C2/C5 viruses penetrate into the cytosol from an as-
yet-unidentified early endosomal compartment (15, 20), whereas penetration of 
species B adenoviruses has been postulated to occur from late endosomes (29). 
 
Escape of incoming adenoviruses from endosomes is dependent on the viral 
membrane lytic protein VI (30, 31).  To expose protein VI from the inside of the virus, 
the virus uses CAR to engage in actomyosin-2-dependent drifting motions on the cell 
surface, and uses integrin binding for confinement (32).  These two counteracting 
motions lead to a mechanical strain that releases fibers and causes structural 
changes in the particle that enable efficient exposure of protein VI (32).  The escape 
of HAdV-C2/5 is apparently mediated by protein VI-induced disruption of an 
endosomal membrane, since HAdV-C2/C5 can promote delivery of co-internalized 
70-kDa dextran, 25 nm parvovirus particles or membrane-impermeable bacterial 
toxins into the cytosol (31, 33-35).  Furthermore, recombinant protein VI fragments 
liposomes in vitro (30).  Critical for membrane disruption is an N-terminal amphipathic 
α-helix in protein VI (30, 31, 36, 37).  In HAdV-C2_TS1 mutant virus (TS1) the capsid 
cementing proteins are unprocessed due to a point mutation in the viral protease 
(16).  This mutant virus is unable to undergo structural changes that enable 
penetration during entry, and the virus particles end up trapped in late 
endosomes/lysosomes (14, 20, 32, 38).   
 
A controversial question in the penetration of HAdV-C2/C5 viruses has been the role 
of acidic endosomal pH.  Although in vitro studies have shown that acidic pH can 
destabilize the virion structure and promote protein VI exposure (30, 39), 
fragmentation of liposomes by recombinant protein VI is a pH-independent reaction 
(30).  Furthermore, delivery of co-internalized dextran into the cytosol in HAdV-C5 
infected cells has been reported to be unaffected by neutralization of endosomal pH 
by the vacuolar H+-ATPase inhibitor bafilomycin A1 (33).  On the other hand, 
 5 
inhibition of endosomal acidification has been reported to reduce cytosolic delivery of 
co-internalized bacterial toxins (35, 40, 41), and overall viral infection efficiency (15, 
42).  However, none of these studies directly monitored cytosolic and endosomal 
virus populations in the infected cells.  Here we report a single cell based imaging 
assay for direct quantification of cytosolic and endosomal viruses during entry into 
cells.  Our results indicate that incoming HAdV-C2/C5 particles rapidly and efficiently 
escape from endosomes, and that efficient membrane penetration does not require 
acidic endosomal pH.  The assay is easily adapted to other adenoviruses, as 
exemplified by HAdV-B3, and potentially also to other non-enveloped viruses.  
 6 
Materials and Methods 
Cells and viruses 
HeLa cervical carcinoma cells, subline Ohio (from L.  Kaiser, University Hospital, 
Geneva, Switzerland) (43),  human bronchial epithelial A549 cells and human 
embryonic retinoblast 911 cells were grown at 37°C under 5% CO2 in Dulbecco’s 
modified Eagle’s medium (DMEM, Sigma) supplemented with 7.5 % FCS (Life 
Technologies) and 1% nonessential amino acids (Sigma).  Human adenoviruses 
HAdV-C2, the penetration deficient mutant HAdV-C2_TS1, HAdV-C5 and HAdV-B3 
were grown in A549 cells, isolated and labeled with Alexa Fluor 488 (Alexa-488, Life 
Technologies) or atto-565 (Atto-tec, Germany) as previously described (14, 15, 44).  
HAdV-C5_EGFP, an E1/E3 deleted mutant virus containing EGFP gene in the E1 
region under the control of cytomegalovirus major immediate early promoter (45, 46), 
as well as the EGFP-expressing, non-replicating HAdV-B3_EGFP virus (47), were 
grown in 911 cells. 
 
Streptolysin O (SLO)-penetration assay 
HeLa-Ohio or A549 cells were seeded on Alcian blue-coated glass coverslips (48) in 
24-well dishes (40000 cells / well) and grown for 2 days.  Alexa-488-labeled viruses 
(~0.5µg virus/well yielding about 10-200 bound particles/cell) were bound to cells at 
0°C for 60 min in RPMI-1640 medium (without NaHCO3, Sigma) supplemented with 
0.2% bovine serum albumin (BSA), 20mM Hepes and penicillin/streptomycin 
(=RPMI-BSA medium). The unbound virus was washed away and the cells in RPMI-
BSA medium were placed into a 37°C water bath.  After virus internalization, cells 
were placed on ice, washed twice with SLO-binding buffer (25 mM Hepes-KOH pH 
7.4, 110 mM potassium acetate, 2.5 mM magnesium acetate, 0.2 mM calcium 
chloride, 1 mM EGTA, 1 mM DTT) and processed for Streptolysin O (SLO)-mediated 
perforation of the plasma membrane.  SLO was kindly provided by M. Husmann and 
S. Bhakdi (University Medical Center, Johannes Gutenberg-University Mainz), or, 
alternatively, purchased from Sigma.  The SLO was pre-activated in SLO-binding 
buffer at room temperature (RT) for 5 min, just before use.  The activated SLO was 
applied to cells in ice-cold SLO binding buffer and bound to the cell plasma 
membrane on ice for 10 min.  The unbound SLO was washed away, and cells in 
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SLO-binding buffer were switched to a 37°C water bath for 5 min to allow 
oligomerization of SLO and pore formation.  The exact amount of SLO needed to 
permeabilise the cells varied between 0.4-3 µg per well depending on the SLO batch.  
After the pore formation step, cells were placed back on ice, washed twice with 
antibody-incubation buffer (25mM Hepes-KOH pH 7.4, 110 mM potassium acetate, 
2.5 mM magnesium acetate, 2 mM EGTA), and incubated with rabbit anti-Alexa-488 
antibody (Life Technologies: antibody diluted in the antibody-incubation buffer) on ice 
for 60 min.  Unbound antibody was washed away, cells were fixed with 3% 
paraformaldehyde (prepared in 25mM Hepes-KOH pH 7.4, 110 mM potassium 
acetate, 2.5 mM magnesium acetate) at RT for 20 min, quenched for 10 min with 25 
mM ammonium chloride in PBS, and permeabilised with 0.5% Triton X-100 in PBS at 
RT for 5min.  Cells were blocked with 10% goat serum, and stained with goat Alexa 
Fluor 594 (Alexa-594)-conjugated anti-rabbit antibodies (Life Technologies), and with 
DAPI to identify the nuclei.  Intact cells incubated with anti-Alexa-488 antibodies in 
RPMI-BSA medium for 1h on ice were used to estimate the number of plasma 
membrane-associated viruses.  SLO-treated samples fixed and permeabilised with 
Triton X-100 before the addition of anti-Alexa-488 antibodies (so called TX-100 
samples) were used to control the overall accessibility of the internalized virus for the 
antibodies. The samples were imaged with Leica SP5 confocal laser scanning 
microscope using 63 × objective (oil immersion, numerical aperture 1.4) and zoom 
factor 2.  Excitations were at 405 nm (DAPI), 488 nm (virus) and 561 or 594 nm 
[antibody signal; excitation was at 633 nm if Alexa Fluor 633 (Alexa-633) or Alexa 
Fluor 680 (Alexa-680) secondary antibodies were used].  Stacks were recorded at 
0.5 µm intervals using 4 × averaging and sequential acquisition for the individual 
channels.  Maximum projections of confocal stacks were analyzed by a custom 
programmed MatLab (The Mathworks) routine to score individual virus particles 
within single cells and to quantify the anti-Alexa-488 antibody signal on the particles 
(49).  The MatLab routines used in this study will be made available upon request.  
The threshold value for positive antibody signal was determined by placing a virus 
image on an antibody image obtained from non-infected cells and taking the highest 
virus-associated antibody signal as a cut-off value.  As with any thresholds, 
classification mistakes may occur due to particles that have values close to the 
threshold.  With our procedure, less than 3.5% of particles had values within 20% of 
the threshold value (see for example Fig. 1D), indicating that the thresholding errors 
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are small.  Further, over 95% of viruses in the TX-100 samples had an anti-Alexa-
488 signal higher than the threshold value indicating that this thresholding procedure 
efficiently detected most of the viruses.  Representative images shown in figures 
were processed with Image J applying the same changes in brightness and contrast 
to all image groups in the series (http://rsbweb.nih.gov/ij/). 
 
For wild type (wt) HAdV-C2 and TS1 virus coinfection, unlabeled wt and Alexa-488-
labeled TS1 were bound to HeLa-Ohio cells at cold to synchronize the infection, and 
subsequently internalized at 37°C for 30 min before permeabilization with SLO as 
described above.  Mean number of bound wt viruses per cell was 99, and 40 for TS1.  
The wt and TS1 viruses in the SLO-treated cells were detected with mouse anti-
hexon 9C12 antibody (50) and anti-Alexa-488 antibody, respectively.  Secondary 
antibodies were Alexa-680-conjugated goat anti-mouse and Alexa-594-conjugated 
goat anti-rabbit, respectively.  The 9C12 antibody, developed by Laurence Fayadat 
and Wiebe Olijve, was obtained from Developmental Studies Hybridoma Bank 
developed under the auspices of the NICHD and maintained by the University of 
Iowa, Department of Biology, Iowa City, IA 52242. 
 
Simultaneous detection of surface, endosomal and cytosolic viruses in cells infected 
with Alexa-488-labeled wild type HAdV-C5 was carried out by first incubating intact 
cells with anti-hexon 9C12 antibody in RPMI-BSA medium for 1h on ice.  After 
removing unbound antibodies, cells were permeabilized with SLO and incubated with 
anti-Alexa-488 antibodies as described above. Secondary antibodies were Alexa-
633-conjugated anti-rabbit and Alexa-594-conjugated anti-mouse.  Particles that 
scored positive for 9C12 antibody were classified as surface viruses, and particles 
that were 9C12-negative, but anti-Alexa-488-positive were classified as cytosolic 
viruses.  Single antibody stainings were used to control that there were no signal 
spillover artefacts. 
To determine the effect of endosome neutralization on virus penetration, the cells 
were pre-incubated with Bafilomycin A1 (Baf A1, Sigma, 50 nM in growth medium), 
niclosamide (Sigma, 5 µM in plain RPMI-1640 medium, 51) and NH4Cl (25mM in 
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RPMI-BSA pH 8.2 medium) for 1h before the virus addition.  Control cells were 
treated with dmso (Baf A1 and niclosamide) or the pH 8.2 RPMI-BSA medium 
(NH4Cl).  The assay was carried out as described above, except that virus binding 
and internalization were in media containing the drugs.  To control the effectiveness 
of the drugs and NH4Cl, cells were incubated in RPMI-BSA medium containing 2 µM 
Lysotracker DND-99 (Life Technologies) at RT for 15 min after the drug pretreatment, 
washed twice with PBS and fixed with 3% paraformaldehyde containing 3 µg/ml 
Hoechst 33342 (Sigma).   
 
EM assay for penetration 
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with 
dmso (control), Baf A1 or niclosamide for 1h as described above.  Fifteen µg of 
HAdV-C2 was bound to cells at cold and the virus was internalized at 37°C for 30 min 
in the presence of dmso or the drugs.  Samples were processed for electron 
microscopy as previously described (20).  For quantification, digital micrographs were 
recorded in sections across the middle of the cells imaged at 50000x magnification 
as described (52).  The number of viruses at the plasma membrane, in endosomes 
and the cytosol was determined by manual counting. 
 
Assay for protein VI exposure 
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with 
Baf A1, niclosamide or ammonium chloride for 1 h as described above, and the drugs 
were present in the medium throughout the experiment.  Atto565-labeled HAdV-C5 
was bound to cells at cold, and internalized at 37°C for indicated times.  After 
internalization, intact cells were incubated with the 9C12 anti-hexon antibody on ice 
to tag virus particles at the cell surface.  Cells were fixed with 3% paraformaldehyde 
and processed for anti-protein VI staining (see above, and 32).  Alexa-680-
conjugated goat anti-mouse and Alexa-488-conjugated goat anti-rabbit were used as 
secondary antibodies.  The samples were imaged as described above.  A custom 
programmed MatLab routine was used to quantify protein VI signal on endocytosed 
viruses, that is, Alexa-565-positive, but Alexa-680-negative viruses. 
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Assay for incoming nuclear protein VII 
HeLa-Ohio cells grown on Alcian blue-coated glass coverslips were pretreated with 
dmso, Baf A1 or niclosamide for 1h as described above.  HAdV-C5 was bound to 
cells at 37°C for 30 min in the presence of dmso or drugs, after which virus inoculum 
was removed and cells were either fixed with 3% paraformaldehyde (30 min sample) 
or further incubated at 37°C for 2.5 h in the presence of dmso or drugs before fixation 
(2.5 h sample).  The samples were processed for immunofluorescence as described 
above.  Anti-hexon 9C12 and Alexa-488-conjugated goat anti-mouse antibodies were 
used to estimate the number of virus particles bound per cell (30 min sample), and 
rabbit anti-protein VII (53) and Alexa-488-conjugated goat anti-rabbit antibodies were 
used to visualize nuclear protein VII dots in the 2.5 h sample.  DAPI was used to 
mark the nuclear area.  Cells were imaged as described above.  Number of viruses 
per cell was analyzed by a custom programmed MatLab routine from maximum 
projections of confocal stacks, and the number of nuclear protein VII dots was 
analyzed by CellProfiler (http://cellprofiler.org).   
 
Infection assays 
To determine the effect of Baf A1 on virus infection, HeLa-Ohio cells grown on 96-
well imaging plates (Greiner Bio-one) were pretreated with Baf A1 or dmso for 60 min 
as described above.  HAdV-C5_EGFP or HAdV-B3_EGFP virus was bound to cells 
at 37°C for 30 min, after which virus inocula were removed and cells further 
incubated at 37°C for 17-18 h in growth medium containing dmso/Baf A1.  
Alternatively, dmso/Baf A1 were added 2 h after removal of virus inocula.  The 
samples were fixed, processed and imaged as described (32).  DAPI stain was used 
to mark the nuclear area, and custom programmed MatLab routine was used to 
determine the average nuclear intensity of the EGFP signal, which was taken as a 
measure of infection efficiency.  To determine the effect of niclosamide on virus 
infection, HeLa-Ohio cells grown on 96-well imaging plates were pretreated with 
niclosamide or dmso for 60 min as described above, HAdV-C5_EGFP or HAdV-
B3_EGFP virus was then bound to cells at 37°C for 30 min, after which virus inocula 
were removed and cells further incubated at 37°C for 3.5 h in the presence of 
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dmso/niclosamide, followed by 13-14.5 h incubation in a drug-free growth medium.  
Cells were processed and analyzed as described for the Baf A1 experiment. 
 
 
Results 
Endocytosed HAdV-C2 rapidly escapes from endosomes  
Previous studies have suggested that species C human adenoviruses, such as 
HAdV-C2 and HAdV-C5, escape from early endosomes by causing disruption of the 
endosomal membrane (15, 20, 30).  To quantitatively monitor the escape at single-
cell level, we developed the assay outlined in Fig. 1A.  The assay uses Alexa-488-
labeled viruses, anti-Alexa-488 antibodies and the bacterial toxin Streptolysin O 
(SLO) (54).  Virus particles are first bound to cells at cold to synchronize infection 
and cells are then switched to 37°C for virus internalization.  After internalization, the 
plasma membrane of the infected cells is perforated by SLO.  This allows access of 
anti-Alexa-488 antibodies into the cytosol and decoration of cytosolic viruses by the 
antibodies.  In contrast, virus in endosomes is not accessible to the antibodies.  
Incubation of the permeabilised cells with antibodies is done at cold in a buffer devoid 
of ATP to suppress penetration of virus after SLO-permeabilization.  After the primary 
antibody treatment, cells are fixed, permeabilised and stained with secondary Alexa-
594-conjugated antibodies, and imaged by confocal microscopy.  Cytosolic virus 
particles are recognized by the dual Alexa-488 and Alexa-594 signals, whereas 
endosomal viruses have only the Alexa-488 signal.  Since viruses at the cell surface 
are also accessible to antibodies, the assay includes control samples stained with 
anti-Alexa-488 antibodies without prior SLO-permeabilization.  Fig. 1B shows 
representative confocal images of HeLa-Ohio cells infected with Alexa-488-labeled 
wt HAdV-C2 or the penetration-deficient TS1 virus.  The majority of wt particles were 
accessible to the anti-Alexa-488 antibodies 30 min post infection (pi), unlike TS1.  
Following uptake, TS1 particles are transported to late endosomes (20), and this 
explains the clustering of TS1 (Fig. 1B).   
 
To determine the kinetics and efficiency of wt virus penetration, HeLa-Ohio cells  
infected with Alexa-488-labeled wt HAdV-C5 were analyzed at 0, 5, 10 or 20 min 
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after virus internalization.  Intact cells were first stained with mouse anti-hexon 9C12 
antibody, then permeabilized with SLO and incubated with the rabbit anti-Alexa-488 
antibodies.  After fixation, cells were permeabilized and stained with secondary 
Alexa-594-conjugated anti-mouse and Alexa-633-conjugated anti-rabbit antibodies, 
and imaged by confocal microscopy (Fig. 1C).  Particles positive for 9C12 were 
classified as surface particles, and particles negative for 9C12, but positive for anti-
Alexa-488 antibodies were classified as cytosolic viruses.  Surface stains at the 0 min 
time point indicated that Alexa-488-labeled HAdV-C5 was efficiently recognized by 
both antibodies.  After 5 min, about 47% of particles were at the cell surface and 39% 
in the cytosol.  The surface population decreased to 13% and 1% at the 10 min and 
20 min points in time, respectively, and the cytosolic population increased to 67% 
and 79%, respectively.  Note that the size of surface and cytosolic virus populations 
varied considerably from cell-to-cell at 5 min and 10 min post internalization.  Since 
the endosomal virus population at any of the time points amounted only to maximum 
of about 20%, this suggests that HAdV-C5 rapidly penetrates after endocytosis.  
 
A time course was done with TS1-infected cells (Fig. 1D).  Unfortunately, we could 
not score surface, endosomal and cytosolic viruses within the same cell, since TS1 is 
not recognized by the 9C12 antibody.  Instead, intact cells stained with anti-Alexa-
488 antibodies were used to estimate the size of surface virus population.  Parallel 
SLO-permeabilized samples were stained with the same antibody to estimate the 
size of the cytosolic virus population.  Significantly, the percentage of TS1 particles 
positive for anti-Alexa-488 antibody was similar in the 5 min surface and SLO-treated 
samples.  Since the endocytosed TS1 particles at this time point are expected to be 
in early endosomes (20), this result indicates that early endosomes remain intact in 
the SLO-treated samples.  Also the integrity of late endosomes appeared not to be 
compromised in the SLO-treated samples, since the vast majority of TS1 particles 
were not accessible to anti-Alexa-488 antibodies after 30 min of internalization, a 
time point when viruses have reached the late endosomes (20).  TS1 virus 
preparations always contain some wt-like, penetration competent particles.  A 
previous transmission-EM study estimated that 14% of incoming TS1 particles were 
found in the cytosol at 30 min post internalization (16).  The 10% mean penetration 
efficiency of TS1 at 30 min post internalization in the present study agrees well with 
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these previous results.  If SLO-perforated TS1-infected cells were fixed and 
permeabilised with Triton X-100 prior to staining with anti-Alexa-488 antibodies, then 
all TS1 particles became decorated with the antibody (Fig. 1D).   
 
We next tested the penetration efficiency of TS1 in HAdV-C5 (wt) and TS1 co-
infected cells to test the possibility that wt infection generally destabilized endosomes 
in the SLO-permeabilised cells.  Unlabeled HAdV-C5 and Alexa-488-labeled TS1 
particles were bound to HeLa-Ohio cells at cold and cells were permeabilised with 
SLO 30 min pi.  As shown in Fig. 1E, HAdV-C5 particles were readily accessible to 
antibodies in the SLO-permeabilised cells.  More TS1 particles were antibody-
positive in cells co-infected with HAdV-C5 than in the single TS1 infection (3% 
compared to 8.5%), and the difference was statistically highly significant (P<0.0001, 
two-tailed Mann-Whitney test).  Previous results from our laboratory indicated that 
maximally 7.5% of incoming HAdV-C2 co-localized with the early endosomal marker 
EEA1, and that 65% of HAdV-C2-positive early endosomes were also positive for 
TS1 in wt and TS1 co-infected cells (20).  Thus wt virus is expected to enhance 
cytosolic delivery of TS1 in a co-infection situation, and this most likely explains the 
differences between TS1 single and wt-TS1 co-infections in Fig.1E.  Notably, the 
overall number of antibody-positive TS1 particles in the co-infection was low in 
comparison to wt virus infections.  The data thus indicate that wt virus infection does 
not lead to nonspecific disruptions of endosomes in presence of SLO.   
 
So far, the experiments were done in HeLa-Ohio cells.  We next tested the assay in 
A549 cells using Alexa-488-labeled HAdV-C2 (wt) or TS1 (Fig. 2).  Parallel intact or 
SLO-permeabilized cells were incubated with anti-Alexa-488 antibodies 20 min post 
virus internalization.  A minor fraction of HAdV-C2 remained at the plasma 
membrane at this time point.  The vast majority of HAdV-C2 in the SLO-treated cells 
was accessible to anti-Alexa-488 antibodies indicating rapid and efficient virus 
penetration in these cells as well.  The differences of intact and SLO-treated TS1 
samples were not statistically significant.  Taken together, the results suggest that 
our assay allows quantitative assessments of cytosolic and endosomal virus 
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populations.  The results demonstrate that endocytosed wt HAdV-C rapidly and 
efficiently penetrates into the cytosol.   
 
Acidic endosomal pH is not required for efficient penetration of HAdV-C2 
To neutralize endosomal compartments we used different compounds blocking low 
endosomal pH by three different modes of action, bafilomycin A1 (Baf A1) blocking 
the v-ATPase (55), niclosamide acting as a protonophore (51) and NH4Cl acting as a 
lysosomotropic weak base (56, 57).  HeLa-Ohio cells were preincubated with the 
drugs for 60 min prior to cold synchronized infection with Alexa-488-labeled HAdV-
C2 or HAdV-C2_TS1.  Control samples were treated with dmso (Baf A1 and 
niclosamide) or with pH 8.2 culture medium (NH4Cl).  As shown by the lysotracker 
DND99 stain, all three drugs efficiently neutralized acidic compartments in cells (Fig. 
3A).   
 
Baf A1 did not inhibit endocytosis of wt HAdV-C2, since in the majority of cells >95% 
virus particles were inaccessible to anti-Alexa-488 antibodies in intact cells (Fig. 3B).  
The percentage of penetrated HAdV-C2 in control SLO-permeabilised cells varied 
between 16.5-89.1% at 20 min pi (mean 64.4%).  Although a greater number of cells 
displayed virus penetration efficiencies < 40% in the Baf A1-treated sample, the 
difference between control and Baf A1 samples was not statistically significant.  The 
TS1 control indicated that endosomes remained intact in the SLO-permeabilised Baf 
A1 samples.  A similar analysis for niclosamide treated cells 60 min pi showed that 
HAdV-C2 was efficiently endocytosed, and the drug did not compromise endosomal 
integrity, as indicated by the TS1 control (Fig. 3C).  Although HAdV-C2 escaped from 
endosomes less efficiently in niclosamide-treated cells (P=0.0011, two-tailed Mann-
Whitney test compared to the control cells), the mean penetration efficiency of HAdV-
C2 was 63.2%, far higher than that of TS1.  Similarly, the escape of wt virus to 
cytosol was significantly less efficient also in NH4Cl treated cells than in control cells 
(Fig. 3D, 30 min pi), but again the overall penetration efficiency was relatively slightly 
affected, in agreement with Baf A1 or niclosamide treated cells.  These results 
strongly suggest that acidic pH in endosomes is not needed for efficient penetration.  
This was in agreement with transmission-EM analyses 30 min post internalization.  
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No statistically significant differences were observed between control and Baf A1, or 
control and niclosamide samples (Fig. 3E and 3F).   
 
We next analyzed the effect of Baf A1, niclosamide and NH4Cl on exposure of the 
viral membrane lytic protein VI.  As previously reported (32), protein VI is 
inaccessible to antibodies in intact virus particles (0 min sample, cold synchronized 
infection), but during early steps in the entry the virus undergoes structural changes 
that result in exposure of protein VI epitopes (Fig. 4A).  Externalization of protein VI is 
a prerequisite for efficient penetration (32).  HeLa-Ohio cells were pretreated with Baf 
A1, niclosamide or NH4Cl for 1 h, atto-565-labeled HAdV-C5 was bound to cells at 
cold, and virus was internalized at 37°C (Fig. 4B-D). We restricted the analysis to 
endocytosed particles because protein VI exposure occurs concomitantly or soon 
after endocytosis (our unpublished observations).  The average protein VI intensity 
on endocytosed particles in Baf A1 treated cells was slightly higher at 10 min pi than 
in control dmso treated cells (Fig. 4B).  Protein VI separates from the virus particle 
following escape of the virus into the cytosol (32), and by 20min post internalization 
the protein VI intensity on endocytosed virions in Baf A1 and control samples was 
reduced to similar levels.  No significant differences on protein VI signal on 
endocytosed particles were observed in control dmso or niclosamide treated cells at 
10 min or 20 min pi (Fig. 4C).  Similarly, NH4Cl did not reduce protein VI exposure 
(Fig. 4D).  Taken together, these results support the conclusion that acidic pH in 
endosomes is not needed for efficient penetration of HAdV-C. 
 
Effect of endosome neutralization of nuclear import of protein VII and 
virus infection 
We tested the effects of Baf A1 and niclosamide on entry steps downstream of 
penetration, such as nuclear targeting of the genome-associated protein VII 2.5 h pi 
(Fig. 5A, B, C).  Low multiplicity of infection, resulting in 4-41 bound virus particles 
per cell was used in the assays, and Baf A1 and dmso treated cells bound virus with 
equal efficiency (Fig. 5A).  As previously described (53, 58), incoming protein VII is 
seen as discreet dots over the nuclear area (Fig. 5B, nuclear area defined by DAPI 
signal).  Quantification of protein VII dots per nucleus indicated that the number of 
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dots correlated with input virus, and similar numbers of dots were observed in dmso 
and Baf A1 treated cells (Fig. 5C).  Nuclear targeting of protein VII was analyzed in 
niclosamide treated cells as well.  Protein VII puncta in niclosamide treated cells 
were, however, less discrete and appeared to be more diffuse than in control cells, 
thus hindering accurate comparisons of the signals in these two samples (data not 
shown).  Instead, we estimated the overall virus entry efficiency in Baf A1 or 
niclosamide treated cells by measuring the transgene expression from HAdV-C5-
EGFP, a non-replicating, E1/E3-deleted virus (45).  Surprisingly, Baf A1 treatment 
boosted infection efficiency by ~ 3.5-fold 17 h pi (Fig. 5D).  However, this boost was 
not linked to penetration, since a significant increase in infection efficiency was also 
seen when Baf A1 was added 2h after removal of virus inoculum.  Similar analyses of 
niclosamide treated cells showed that HAdV-C5-EGFP infection efficiency was ~76% 
of that in the control dmso cells (Fig. 5E).  Collectively, the data demonstrate that 
acidic pH is not required for virus penetration to the cytosol and nuclear import of 
viral DNA-associated protein VII, but pH neutralization by Baf A1 increases 
transgene expression.   
 
Acidic endosomal pH is not required for efficient penetration of HAdV-B3 
Previous studies have shown that incoming HAdV-B traffic to late endosomes and 
lysosomes in larger extent than HAdV-C (29).  We used Alexa-488-labeled HAdV-B3 
as a model to monitor the kinetics of subgroup B virus escape from endosomes, and 
sensitivity of the escape to neutralization of endosomal pH.  HeLa-Ohio cells were 
permeabilised by SLO at 30 min pi showing that a significant number of viruses had 
penetrated into the cytosol as evidenced by their accessibility to anti-Alexa-488 
antibodies, but virus clusters that were negative for anti-Alexa-488 signal were 
observed as well (Fig. 6A, representative images).  Quantitative assessment of 
uptake and escape showed that at 15 min pi, ~96% of viruses were endocytosed, 
and on average ~40% had penetrated into the cytosol (Fig. 6B).  At 30 min pi, the 
penetration efficiency was not significantly different from that at 15 min pi, but 
considerable cell-cell variability in the penetration efficiency was observed, similar to 
HAdV-C.  Similar to HAdV-C, Baf A1 did not inhibit endocytosis of HAdV-B3.  
Quantification of the Alexa-488 and Alexa-594 double positive particles indicated that 
HAdV-B3 penetrated as efficiently in the Baf A1-treated cells as in the control cells 
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(Fig. 6C).  The difference in penetration efficiency of the virus in control compared to 
niclosamide treated cells was statistically significant, but the overall penetration 
efficiency was still high, even in the niclosamide sample (Fig. 6D).  Taken together, 
these results demonstrate that acidic endosomal pH is not required for efficient 
penetration of HAdV-B3.  We were not able to analyze effect of the drugs on HAdV-
B3 protein VI exposure or protein VII nuclear import, since our antibodies did not 
react with HAdV-B3 (data not shown).  Instead, we tested infection efficiency of a 
non-replicating HAdV-B3_EGFP virus in Baf A1-treated cells 18 h pi (47).  If the drug 
was added 1h before the virus, ~4.6-fold boost in the infection efficiency was 
observed (Fig. 6E).  The boost was significantly lower if the drug was added 2h after 
removal of the virus inoculum.  A similar trend was observed in niclosamide treated 
cells (Fig. 6F).  Thus, both Baf A1 and niclosamide boosted HAdV-B3-EGFP infection 
efficiency without having a large effect on the penetration step. 
 
 
Discussion 
In this study, we establish a new penetration assay for adenoviruses that 
quantitatively measures virus escape from endosomes at single-cell level.  SLO-
mediated perforation of the plasma membrane is used to introduce antibodies into 
the cytosol and accessibility of e.g. Alexa-488-labeled virus to anti-Alexa-488 
antibodies distinguishes cytosolic from endosomal viruses in the permeabilised cells.  
Techniques such as delivery of co-internalized dextran or bacterial toxins into the 
cytosol by virus-induced rupture of endosomes (e.g., 33, 35, 40, 59, 60), or counting 
of viruses at the plasma membrane, endosomes and cytosol by EM (e.g., 27, 28, 61) 
have previously been used to estimate escape of HAdV-C and HAdV-B from 
endosomes.  However, the co-delivery assays are bulk assays without single cell 
resolution, and most importantly these assays estimate virus penetration only 
indirectly.  Furthermore, interpretation of the results from co-delivery assays can be 
complicated by the fact that HAdV-C induces macropinocytosis and leakage of 
macropinosomal contents into the cytosol (22, 27).  This uptake pathway could be 
responsible for the delivery of bulk of the co-internalized dextran or bacterial toxins 
into the cytosol, but the macropinocytosis is not the infectious entry pathway at least 
for the HAdV-C (22).  The EM assay on the other hand directly estimates cytosolic 
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and membrane-associated virus particles, but the assay is cumbersome and requires 
very high MOI.   
 
The assay presented in this study can be used at high and low MOI.  It is easy to set-
up because the key components are commercially available - Alexa-488, anti-Alexa-
488 antibody and SLO.  However, there is one limiting factor, the choice of cell lines.  
Not all cells can endure the SLO permeabilisation, and some cell types detach from 
the dish, for example, U2OS cells.  In this study, we used the HeLa-Ohio clone and 
A549 cells.  In agreement with previous studies (e.g., 15, 29), we found that HAdV-
C2 penetrates very rapidly after endocytic uptake.  In a cold synchronized infection, a 
large fraction of viruses had escaped into the cytosol already 10 min after switching 
the cells to 37°C.  Furthermore, the overall penetration efficiency was >60% at 20 
min pi.  Characterization of the early entry events for other adenovirus species is 
lagging behind that of HAdV-C.  Our assay here is readily adaptable to other 
adenoviruses, as exemplified by HAdV-B3.  We found that penetration of HAdV-B3 
occurred rapidly, similar to HAdV-C2.  At 15 min post internalization the overall 
escape efficiency was about 40%.  The single cell resolution of our assay revealed 
considerable cell-to-cell variability in the virus penetration efficiency for both HAdV-
C2 and HAdV-B3.  While the molecular basis of this variability is currently unknown, it 
is interesting to note that the externalization of the viral membrane lytic protein VI to 
the surface of the virus also occurs with different efficiencies in individual cells.   
 
There has been a long standing controversy regarding the role of acidic endosomal 
pH in adenovirus penetration (15, 30, 33, 40, 59, 62).  Our escape assay indicated 
that efficient penetration of HAdV-C2 and HAdV-B3 occurs even if the pH in 
endosomes is neutralized.  Furthermore, efficient exposure of the HAdV-C5 
membrane lytic protein VI did not require acidic pH in endosomes.  This was 
concluded from experiments using three distinct inhibitors to neutralize the 
endosomal pH: Baf A1 (vacuolar H+-ATPase inhibitor), niclosamide (proton carrier) 
and ammonium chloride (lysomotropic weak base).  Although the penetration of 
HAdV-C2 was affected to different degrees by these three treatments, the lysotracker 
control indicated that all three conditions efficiently neutralized acidic compartments 
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in the cell.  The differences in penetration must hence be due to other effects of the 
compounds than endosomal pH neutralization.  Interestingly, especially Baf A1 and 
ammonium chloride significantly reduced HAdV-C2 penetration in a subpopulation of 
the cells, suggesting that other endosomal factors than pH enhance HAdV 
penetration.  Interestingly, a mild acid (pH 6) treatment of cells containing surface-
bound HAdV-C2 increased the release of tritium labeled choline or 51Cr from the cells 
compared to cells kept at neutral pH (62, 63).  Possibly, low pH at the plasma 
membrane can substitute for an endosomal factor(s) in virus induced membrane 
perforation.  
 
Although Baf A1 and niclosamide had relatively minor overall effects on the 
penetration efficiency of HAdV-C2 and HAdV-B3, a different picture emerged when 
the effect of these drugs was tested by EGFP-reporter viruses.  In the case of HAdV-
C5_EGFP virus, Baf A1 boosted infection efficiency by ~3.5-fold, whereas 
niclosamide reduced the infection by ~20%.  In contrast, a significant infection boost 
was observed for HAdV-B3_EGFP virus, with both Baf A1 and niclosamide, possibly 
related to endosomal maturation which has been suggested to increase HAdV-C2 
infection through autophagosome-endosome hybrid compartments (60).  Regardless, 
the data highlight that it is crucial to employ direct assays for on-target interpretation 
of interference and perturbation experiments.  
 
One intriguing observation in the current study was the rather low impact of co-
internalized wt viruses on the penetration efficiency of the TS1 virus.  The average 
penetration efficiency of TS1 in the co-infection was 8.5% and 3% in TS1 single 
infections.  The TS1 virus escapes from endosomes inefficiently because it does not 
undergo the structural alterations that prepare the particle for efficient protein VI 
exposure (14, 32), but it interacts with CAR and integrins, and is internalized by 
clathrin-mediated endocytosis as the wt virus (20).  HAdV-C2/C5 viruses penetrate 
from an as-yet-unidentified early endosomal compartment, since maturation of early 
endosomes to late endosomes is not required for efficient virus escape into the 
cytosol (20).  The observed low impact of co-internalized wt particles on TS1 
penetration could imply that the two viruses are sorted to different endosomal 
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compartments following uptake.  Alternatively, the rapid penetration of wt virus may 
simply reduce co-localization of the two viruses in the same endosome compartment.   
 
In summary, our study describes a quantitative single-cell assay for adenovirus 
escape from endosomes to the cytosol, a step that is poorly characterized at the 
molecular level.  The assay can be used in combination with chemical inhibitors or 
possibly RNAi to probe for cellular regulators of the penetration step (64).  Single-cell 
assays are important since it is becoming increasingly evident that cell-to-cell 
variation is observed in many cellular phenotypes, including virus entry (64).  
Correlation of virus entry and infection efficiencies with particular molecular or 
morphological properties of a single cell will give more accurate information about the 
molecular basis of a given event than an average phenotype acquired in a population 
assay.  We expect that owing to its simplicity and reliability, the assay presented in 
this study also works for other non-enveloped viruses and even enveloped viruses, 
provided that they can be detected by an antibody in the selectively-permeabilised 
cells.  Such an antibody can be directed against a viral nucleo-capsid protein or a 
chemical tag added to the virus, for example Alexa-488, as shown in this study for 
non-enveloped viruses.  
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Figure legends 
Fig.  1: SLO-mediated perforation of the plasma membrane allows 
quantification of cytosolic and endosomal viruses  
(A) Protocol and graphical representation of the assay measuring virus penetration 
into the cytosol of cultured cells.  Plasma membrane-associated and cytosolic viruses 
are detected in green by Alexa Fluor 488 (Alexa-488) plus red (Alexa-594) colors, 
whereas endosomal viruses are exclusively green (Alexa-488).   
(B) Alexa-488-labeled HAdV-C2 wild type (wt), but not the penetration-deficient 
Alexa-488-labeled TS1 particles are accessible to anti-Alexa-488 antibodies in SLO-
treated HeLa-Ohio cells 30 min after internalization.  Images shown represent 
maximum projections of individual confocal stacks.  In the merge image Alexa-488 
and Alexa-594 double positive particles are yellow.  Nuclei (DAPI stain) are blue.  
Scale bar = 10 µm.   
(C) Quantification of surface and cytosolic viruses in cells infected with wt Alexa-488-
labeled HAdV-C5.  Intact cells were stained with both the mouse anti-hexon 9C12  
and rabbit anti-Alexa-488 antibodies at 0 min, whereas at other time points intact 
cells were first incubated with the 9C12 antibody, then SLO-treated and incubated 
with anti-Alexa-488 antibodies.  Primary antibodies were detected by secondary 
Alexa-594-conjugated anti-mouse and Alexa-633-conjugated anti-rabbit antibodies.  
The plot shows percentage of virus particles positive for 9C12 (9C; these particles 
represent surface particles) and particles positive for anti-Alexa-488 antibody, but 
negative for 9C12 (Al; these particles represent cytosolic particles).  One dot 
represents one cell.  Error bars represent the mean ± SEM.  Numbers of cells and 
viruses analyzed are indicated. 
(D) Quantification of anti-Alexa-488 positive particles in cells infected with Alexa-488-
labeled TS1.  In SLO(-) samples, intact cells were stained with the antibody to 
estimate the number of viruses at the plasma membrane, whereas the parallel 
SLO(+) sample indicates the number of antibody positive particles in SLO-treated 
cells.   Difference between SLO(-) and SLO(+) samples represents the cytosolic virus 
population.  TX-100 sample is an SLO-treated sample that was fixed and 
permeabilised with TX-100 before staining with anti-Alexa-488 antibodies. Error bars 
represent the mean ± SEM.  Numbers of cells and viruses analyzed are indicated. 
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(E) The majority of Alexa-488-labeled TS1 particles are endosomal in cells co-
infected with wt and TS1 viruses.  Unlabeled wt HAdV-C5 and Alexa-488-labeled 
TS1 were co-internalized into the cells for 30 min before SLO treatment.  Control 
cells were infected with Alexa-488-labeled TS1 alone.  The SLO-permeabilised cells 
were incubated with mouse 9C12 anti-hexon and rabbit anti-Alexa-488 antibodies at 
cold, fixed and treated with Alexa-680-conjugated anti-mouse and Alexa-594-
conjugated anti-rabbit antibodies and DAPI.  The right hand fluorograph shows that 
wt particles in the wt and TS1 co-infected cells were readily accessible to the anti-
hexon antibody.  The left hand panel shows the percentage of TS1 particles positive 
for anti-Alexa-488 antibody in the TS1 single and the TS1 plus wt double infection 
(one dot represents one cell).  The difference between TS1 single and wt and TS1 
double infection was statistically highly significant (two-tailed Mann-Whitney test). 
 
Fig.  2: Penetration of HAdV-C2 in A549 cells is rapid and efficient 
(A) The majority of Alexa-488-labeled wt HAdV-C2 (upper panel), but not the Alexa-
488-labeled TS1 particles are accessible to anti-Alexa-488 antibodies in SLO-treated 
A549 cells 20 min after internalization.  The experiment was done as described in 
legend to Fig. 1.  Images shown represent maximum projections of individual 
confocal stacks.  In the merge image, Alexa-488 and Alexa-594 double positive 
particles are yellow.  Nuclei (DAPI stain) are blue.  Scale bar = 10 µm.  
(B) Quantification of anti-Alexa-488 positive wt and TS1 particles in intact  (SLO / -) 
or parallel SLO-permeabilized A549 cells (SLO / +) at 20 min post internalization (one 
dot represents one cell).  Error bars represent the mean ± SEM.  Numbers of cells 
and viruses analyzed are indicated. 
  
Fig.  3: Acidic endosomal pH is not required for efficient penetration of 
HAdV-C2  
 
(A) Bafilomycin A1 (Baf A1, 50 nM), niclosamide (5 µM) and NH4Cl (25 mM) 
efficiently neutralize acidic compartments.  HeLa-Ohio cells were treated with the 
indicated concentrations of the drugs for 60 min, incubated with DND-99 lysotracker 
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(red) to stain acidic compartments, fixed and stained with Hoechst dye (blue), and 
analyzed by confocal microscopy.  Control cells for Baf A1 and niclosamide were 
treated with dmso, and the control for NH4Cl was pH 8.2 culture medium.  Images 
shown represent maximum projections of individual stacks (DND-99) or a single 
confocal section (Hoechst).  Scale bar = 10 µm.   
(B) Penetration efficiency of HAdV-C2 in Baf A1-treated cells.  Cells were 
permeabilised with SLO 20 min after virus internalization.  The plot shows 
percentage of virus particles positive for the anti-Alexa-488 antibody (one dot 
represents one cell).  Error bars represent the mean ± SEM.  Numbers of cells and 
viruses analyzed are indicated.   
(C) Penetration efficiency in niclosamide-treated cells.  Cells were permeabilised with 
SLO at 60 min post virus internalization.  Differences between control and 
niclosamide-treated samples in the wt infection were statistically highly significant 
(two-tailed Mann-Whitney test). 
(D) Penetration efficiency in NH4Cl-treated cells.  Cells were permeabilised with SLO 
at 30 min post virus internalization.  Although differences between control and NH4Cl-
treated cells in the wt infection were statistically highly significant, only in minority of 
NH4Cl-treated cells the wt virus penetration efficiency was similar to that of TS1.   
(E) Two representative transmission electron micrographs of control cells 30 min pi, 
showing three cytoplasmic HAdV-C2 (upper panel, arrowheads) and an endosomal 
virus (lower panel, arrow).  Scale bar 200 nm. 
(F) Quantification of HAdV-C2 particles in the cytosol of DMSO control cells, Baf A1 
or niclosamide-treated cells 30 min pi, as percent of total particles associated with 
the cells based on transmission EM analyses.  One dot represents one cell.   
 
Fig.  4: Neutralization of endosomal pH does not inhibit exposure of the 
viral membrane lytic protein VI   
(A) Immunofluorescence labeling of protein VI (green) in HeLa-Ohio cells infected 
with Ad5-atto-565 (red).  Ad5-atto-565 was bound to cells at cold and internalized at 
37°C for 0 min or 10 min.  Cells were fixed and stained for protein VI.  Images 
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represent maximum projections of individual stacks.  The protein VI-positive particles 
in the merge image are shown in yellow, and nuclei (DAPI) in blue.  Scale bar = 10 
µm.   
(B) Protein VI exposure in infected Baf A1-treated cells.  The cells were pretreated 
with dmso or the drug for 60 min, atto-565-labeled Ad5-wt particles were bound to 
cells at cold and internalized for the indicated times in the presence of dmso/drug.  
Intact cells were first stained with mouse anti-hexon 9C12 antibody on ice to tag 
surface particles, fixed, permeabilised with Triton X-100 and stained with rabbit anti-
protein VI antibodies.  Secondary Alexa-680-conjugated anti-mouse and Alexa-488-
conjugated anti-rabbit antibodies were used to detect the 9C12 and anti-protein VI 
antibodies, respectively.  Nuclei were stained with DAPI.  Samples were imaged by 
confocal microscopy and images from maximum projections of confocal stacks were 
analyzed by a custom programmed MatLab routine to quantitate the Alexa-488-signal 
on endocytosed virus particles (atto-565-positive, but Alexa-680-negative viruses).  
The plot shows mean fluorescent protein VI signal on endocytosed particles (arbitrary 
units: one dot represents the mean value from one cell).  Error bars represent the 
mean ± SEM.  Protein VI signal on endocytosed viruses in Baf A1-treated cells was 
slightly, but statistically significantly, higher than that in control cells at 10 min post 
virus internalization (two-tailed Mann-Whitney test).  Numbers of cells and viruses 
analyzed are indicated.  Protein VI separates from virus particles after penetration, 
which is indicated by the reduced protein VI signal on viruses 20 min post-
internalization.   
(C) Protein VI exposure in infected, niclosamide-treated HeLa-Ohio cells.  The 
experiment was carried out as in (B). 
(D) Protein VI exposure in infected, NH4Cl-treated HeLa-Ohio cells.  The experiment 
was carried out as in (B).   
 
Fig.  5: Nuclear delivery of incoming viral DNA associated protein VII and 
viral transgene expression are not inhibited by low pH-neutralization   
(A) Dmso and Baf A1 treated cells bind similar amounts of virus.  HeLa-Ohio cells 
were pretreated with dmso or 50 nM BAFA1 for 1h.  HAdV-C5 was bound to cells at 
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37°C for 30 min in the presence of dmso/Baf A1.  Unbound virus was washed away, 
cells were fixed and immunostained with anti-hexon 9C12 antibody and DAPI for 
nucleus.  Samples were imaged by confocal microscopy, and analyzed by custom 
programmed MatLab routine.  The plot shows number of viruses per cell (one dot 
represents one cell).  The error bar represents the mean ± SEM.  Number of cells 
and viruses analyzed are indicated. The differences between dmso and BAFA1 
samples were not statistically significant. 
(B) Immunofluorescence labeling of protein VII in HeLa-Ohio cells infected with 
HAdV-C5 for 3 h.  Images shown represent maximum projections of confocal stacks 
(protein VII, green) or a single confocal section (DAPI, blue).  Incoming protein VII is 
seen as discreet dots over the nuclear area.  Staining of non-infected cells is shown 
as a control for signal specificity.  Scale bar = 10 µm.   
(C) Quantification of nuclear protein VII dots at 3 h post virus internalization indicates 
that nuclear import of protein VII occurs as efficiently in Baf A1-treated cells as in 
control cells.  Error bars represent the mean ± SEM.  The number of nuclei analyzed 
is shown below the plot.  Comparison of samples infected with 60 ng or 30 ng of virus 
indicate that the number of nuclear protein VII dots correlates with input virus.   
(D) Baf A1 boosts HAdV-C5_GFP infection.  Cells were pretreated with dmso or Baf 
A1 for 60 min, a non-replicating HAdV-C5_GFP reporter virus was bound to cells for 
30 min at 37°C and the cells were further incubated at 37°C for 17 h in the presence 
of dmso/Baf A1 (-60min sample).  Alternatively, dmso/Baf A1 was added 2 h after 
virus binding (+120min sample).  Cells were fixed, stained with DAPI, and imaged by 
automated fluorescence microscopy.  The average intensity of EGFP over a DAPI 
mask was quantitated by a custom programmed MatLab routine.  The effect of the 
drug treatment on cell viability (estimated by cell adhesion) is indicated by the cell 
number.  The values represent mean values from three parallel samples ±SD.  Since 
Bafilomycin A1 boosted infection efficiency even when added 2 h after virus binding, 
the boost is not connected to penetration.   
(E) Niclosamide slightly reduces the infection efficiency.  HeLa-Ohio cells were 
pretreated with dmso/drug for 60 min.  Virus was bound to cells at 37°C for 30 min 
and cells were further incubated at 37°C for 3.5 h in the presence of 
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dmso/niclosamide, followed by 14.5 h incubation in drug-free medium.  The samples 
were processed as described in (D). 
 
Fig.  6: Efficiency of HAdV-B3 penetration and infection in Baf A1- and 
niclosamide-treated cells   
(A) SLO-mediated perforation of the plasma membrane allows detection of cytosolic 
but not endosomal virus population in HAdV-B3-infected cells.  Alexa-488 
(Alexa488)-labeled HAdV-B3 was bound to HeLa-Ohio cells at cold and internalized 
at 37°C for 30 min before SLO-permeabilization of cells.  The samples were 
processed and analyzed as described in Fig. 1A.  Images represent maximum 
projections of individual stacks.  In the merge image cytosolic virus is yellow.  Nuclei 
(DAPI signal) are blue.  Scale bar = 10 µm.   
(B) Time course of HAdV-B3 penetration. 
(C) Baf A1 does not inhibit penetration of HAdV-B3.  Cells were pretreated with dmso 
or Baf A1 for 1 h, Alexa-488-labeled virus was bound to cells at cold and internalized 
at 37°C for 1 h in presence of dmso/drug before SLO-permeabilization.  SLO(-)-
sample represents intact cells treated with anti-Alexa-488 antibody at cold to detect 
surface particles.  The plot shows percentage of virus particles positive for the anti-
Alexa-488 antibody (one dot represents one cell).  Error bars represent the mean ± 
SEM.  Number of cells and viruses analyzed are indicated.   
(D) Niclosamide slightly, but statistically significantly, reduces the penetration of 
HAdV-B3.  The experiment was done as described in (C).  Two-tailed Mann-Whitney 
test was used for statistical analyses. 
(E) Baf A1 boosts the infection efficiency.  The experiment was carried out as 
described in legend to Fig. 5D, except that cells were fixed 18 h after removal of virus 
inoculum.  In contrast to HAdV-C5_EGFP, late addition of the drug significantly 
reduced the infection boost.   
(F) Niclosamide boosts the infection efficiency.  The experiment was carried out as 
described in legend to Fig. 5E, except that cells were fixed 13 h after drug removal. 
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